eFFECTOR Therapeutics Inc (FRA:LWK)
€ 1.07 -0.005 (-0.47%) Market Cap: 5.14 Mil Enterprise Value: 345,000.00 PE Ratio: 0 PB Ratio: 5.52 GF Score: 21/100

eFFECTOR Therapeutics Inc R&D Day Transcript

Jan 24, 2024 / 09:30PM GMT
Release Date Price: €9.1
Operator

Good afternoon, and thank you for joining the eFFECTOR investor event. (Operator Instructions) As a reminder, this event is being recorded and a replay will be made available on the eFFECTOR website following the conclusion of the call. I would now like to turn the call over to your host, Steve Worland, President and Chief Executive Officer. Please go ahead, sir.

Steve Worland eFFECTOR Therapeutics
Inc. - President & CEO

Thank you, Sarah, and thank you, everybody, for joining us today for our R&D event. We're really excited to present our information and our assessment of the market opportunities. Just to remind you, we will make some forward-looking statements, so I encourage you to look to our filings with the SEC.

For the agenda today, I'll do a very brief company introduction. And then for both tomi and zota, we'll do a analysis of the unmet medical need and the opportunities there, brief non-clinical overview, and then the clinical overview by Dr. Warner. With regard to zotatifin, we're fortunate to have Dr. Kevin Kalinsky from Emory join

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot